| Bioactivity | Xanthine oxidoreductase-IN-2 (Compound IVa) is a xanthine oxidoreductase (XOR) inhibitor with the IC50 of 7.2 nM. Xanthine oxidoreductase-IN-2 shows hypouricemic effects in mice[1]. |
| Name | Xanthine oxidoreductase-IN-2 |
| CAS | 2396612-45-4 |
| Formula | C21H21N3O2 |
| Molar Mass | 347.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Haiyan Zhou, et al. Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors. Eur J Med Chem. 2020 Jan 15;186:111883. |
Xanthine oxidoreductase-IN-2
CAS: 2396612-45-4 F: C21H21N3O2 W: 347.41
Xanthine oxidoreductase-IN-2 (Compound IVa) is a xanthine oxidoreductase (XOR) inhibitor with the IC50 of 7.2 nM. Xanthi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.